Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Comprehensive Clinical Development, Inc.
mi
from
St Petersburg, FL
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Comprehensive Clinical Development, Inc.
mi
from
St Petersburg, FL
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Clinical Research of Central Florida
mi
from
Winter Haven, FL
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Clinical Research of Central Florida
mi
from
Winter Haven, FL
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Synergy Therapeutic Partners
mi
from
Atlanta, GA
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Synergy Therapeutic Partners
mi
from
Atlanta, GA
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
CTL Research
mi
from
Eagle, ID
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
CTL Research
mi
from
Eagle, ID
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Cedar-Crosse Research Center
mi
from
Chicago, IL
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Cedar-Crosse Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
LaPorte County Institute for Clinical Research Inc.
mi
from
Michigan City, IN
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
LaPorte County Institute for Clinical Research Inc.
mi
from
Michigan City, IN
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
L-MARC Research Center
mi
from
Louisville East, KY
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
L-MARC Research Center
mi
from
Louisville East, KY
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Horizon Research Group of Opelousas, LLC
mi
from
Eunice, LA
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Horizon Research Group of Opelousas, LLC
mi
from
Eunice, LA
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
MD Medical Research
mi
from
Oxon Hill, MD
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
MD Medical Research
mi
from
Oxon Hill, MD
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
IRC Clinics, Inc.
mi
from
Towson, MD
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
IRC Clinics, Inc.
mi
from
Towson, MD
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Endeavor Medical Research, PLC
mi
from
Alpena, MI
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Endeavor Medical Research, PLC
mi
from
Alpena, MI
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Associated Internal Medicine Specialists, PC
mi
from
Battle Creek, MI
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Associated Internal Medicine Specialists, PC
mi
from
Battle Creek, MI
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Albuquerque Clinical Trials
mi
from
Albuquerque, NM
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Albuquerque Clinical Trials
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Pmg Research Of Charlotte
mi
from
Charlotte, NC
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Pmg Research Of Charlotte
mi
from
Charlotte, NC
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Pharmquest
mi
from
Greensboro, NC
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Pharmquest
mi
from
Greensboro, NC
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Clinical Inquest Center, Ltd.
mi
from
Beavercreek, OH
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Clinical Inquest Center, Ltd.
mi
from
Beavercreek, OH
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Infinity Research Group, LLC
mi
from
Oklahoma City, OK
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Infinity Research Group, LLC
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Southeastern Research Associates, Inc.
mi
from
Taylors, SC
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Southeastern Research Associates, Inc.
mi
from
Taylors, SC
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Holston Medical Group
mi
from
Bristol, TN
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Holston Medical Group
mi
from
Bristol, TN
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
New Phase Research & Development
mi
from
Knoxville, TN
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
New Phase Research & Development
mi
from
Knoxville, TN
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
UT Southwestern Medical Center
mi
from
Dallas, TX
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Texas Center for Drug Development, PA
mi
from
Houston, TX
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Texas Center for Drug Development, PA
mi
from
Houston, TX
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Excel Clinical Research, Llc
mi
from
Houston, TX
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Excel Clinical Research, Llc
mi
from
Houston, TX
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Humble Cardiology Associates
mi
from
Humble, TX
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Humble Cardiology Associates
mi
from
Humble, TX
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Cetero Research
mi
from
San Antonio, TX
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Cetero Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Highland Clinical Research
mi
from
Salt Lake City, UT
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Highland Clinical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Jean Brown Research
mi
from
Salt Lake City, UT
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Jean Brown Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Customer Support Response Study
Evaluation of Customer Support Issues, Questions, or Alleged Complaints Regarding Use of Approved Commercially Distributed Scout DS Product in the Field
Status: Enrolling
Updated:  7/17/2012
VeraLight
mi
from
Albuquerque, NM
Customer Support Response Study
Evaluation of Customer Support Issues, Questions, or Alleged Complaints Regarding Use of Approved Commercially Distributed Scout DS Product in the Field
Status: Enrolling
Updated: 7/17/2012
VeraLight
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
Monthly Ranibizumab Versus Treat and Extend Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  7/19/2012
Retina Vitreous Associates of Florida
mi
from
Clearwater, FL
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
Monthly Ranibizumab Versus Treat and Extend Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 7/19/2012
Retina Vitreous Associates of Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
Monthly Ranibizumab Versus Treat and Extend Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  7/19/2012
Retina Vitreous Associates of Florida
mi
from
St. Petersburg, FL
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
Monthly Ranibizumab Versus Treat and Extend Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 7/19/2012
Retina Vitreous Associates of Florida
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Diabetes Visual Function Supplement Study
Effects of a Novel Dietary Supplement on Visual Function in Patients With Diabetes With and Without Early Diabetic Retinopathy
Status: Enrolling
Updated:  7/19/2012
Chous Eye Care Associates
mi
from
Tacoma, WA
Diabetes Visual Function Supplement Study
Effects of a Novel Dietary Supplement on Visual Function in Patients With Diabetes With and Without Early Diabetic Retinopathy
Status: Enrolling
Updated: 7/19/2012
Chous Eye Care Associates
mi
from
Tacoma, WA
Click here to add this to my saved trials
Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
Status: Enrolling
Updated:  7/26/2012
Brigham and Women's Hosp
mi
from
Boston, MA
Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
Status: Enrolling
Updated: 7/26/2012
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis
Official Title: A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Dose, 2-Period Crossover Study to Evaluate the Pharmacodynamics of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated:  7/26/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis
Official Title: A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Dose, 2-Period Crossover Study to Evaluate the Pharmacodynamics of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated: 7/26/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics
Liraglutide and Insulin-001 A Randomized Prospective Trial of Liraglutide Added to High-Dose Insulin Therapy vs. High-Dose Insulin Therapy Alone in Insulin-Resistant Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/30/2012
Mountain Diabetes and Endocrine Center
mi
from
Ashville, NC
Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics
Liraglutide and Insulin-001 A Randomized Prospective Trial of Liraglutide Added to High-Dose Insulin Therapy vs. High-Dose Insulin Therapy Alone in Insulin-Resistant Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/30/2012
Mountain Diabetes and Endocrine Center
mi
from
Ashville, NC
Click here to add this to my saved trials
High Protein and Exercise Therapy Plus Nocturnal Enteral Feeding in Juvenile-onset Pompe Disease
High Protein Nutrition and Exercise Therapy (HPET) Plus Nocturnal Enteral Feeding (NEF) in Juvenile-onset Pompe Disease.
Status: Enrolling
Updated:  8/2/2012
Columbia University Medical Center
mi
from
New York, NY
High Protein and Exercise Therapy Plus Nocturnal Enteral Feeding in Juvenile-onset Pompe Disease
High Protein Nutrition and Exercise Therapy (HPET) Plus Nocturnal Enteral Feeding (NEF) in Juvenile-onset Pompe Disease.
Status: Enrolling
Updated: 8/2/2012
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
A Randomized Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes Who Were Previously Treated by Basal Insulin Glargine With Either Metformin or Metformin and Sulfonylurea
Status: Enrolling
Updated:  8/3/2012
Clinical Research Facility
mi
from
Phoenix, AZ
A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
A Randomized Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes Who Were Previously Treated by Basal Insulin Glargine With Either Metformin or Metformin and Sulfonylurea
Status: Enrolling
Updated: 8/3/2012
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
A Randomized Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes Who Were Previously Treated by Basal Insulin Glargine With Either Metformin or Metformin and Sulfonylurea
Status: Enrolling
Updated:  8/3/2012
Clinical Research Facility
mi
from
Houston, TX
A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
A Randomized Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes Who Were Previously Treated by Basal Insulin Glargine With Either Metformin or Metformin and Sulfonylurea
Status: Enrolling
Updated: 8/3/2012
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis
Status: Enrolling
Updated:  8/8/2012
WellBound of San Jose
mi
from
San Jose, CA
A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis
Status: Enrolling
Updated: 8/8/2012
WellBound of San Jose
mi
from
San Jose, CA
Click here to add this to my saved trials
Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes
Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes
Status: Enrolling
Updated:  8/9/2012
ICON Development Solutions, Gault Lane
mi
from
San Antonio, TX
Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes
Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes
Status: Enrolling
Updated: 8/9/2012
ICON Development Solutions, Gault Lane
mi
from
San Antonio, TX
Click here to add this to my saved trials
Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus
Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  8/9/2012
ICON Development Solutions, Gault Lane
mi
from
San Antonio, TX
Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus
Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/9/2012
ICON Development Solutions, Gault Lane
mi
from
San Antonio, TX
Click here to add this to my saved trials
Improving Diabetes Through Lifestyle and Surgery
Improving Diabetes Through Lifestyle and Surgery Study
Status: Enrolling
Updated:  8/14/2012
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Improving Diabetes Through Lifestyle and Surgery
Improving Diabetes Through Lifestyle and Surgery Study
Status: Enrolling
Updated: 8/14/2012
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002 AM1)
A Multiple Dose Clinical Trial to Study the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Healthy Overweight/Obese Subjects and Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
mi
from
Tampa, FL
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002 AM1)
A Multiple Dose Clinical Trial to Study the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Healthy Overweight/Obese Subjects and Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Weight Loss Study for People With Type 2 Diabetes
Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes
Status: Enrolling
Updated:  8/17/2012
Diabetes Research and Training Center, University of Alabama at Birmingham
mi
from
Birmingham, AL
Weight Loss Study for People With Type 2 Diabetes
Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes
Status: Enrolling
Updated: 8/17/2012
Diabetes Research and Training Center, University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Weight Loss Study for People With Type 2 Diabetes
Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes
Status: Enrolling
Updated:  8/17/2012
Scripps Clinical Research
mi
from
La Jolla, CA
Weight Loss Study for People With Type 2 Diabetes
Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes
Status: Enrolling
Updated: 8/17/2012
Scripps Clinical Research
mi
from
La Jolla, CA
Click here to add this to my saved trials
Weight Loss Study for People With Type 2 Diabetes
Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes
Status: Enrolling
Updated:  8/17/2012
CSRA Partners in Health
mi
from
Augusta, GA
Weight Loss Study for People With Type 2 Diabetes
Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes
Status: Enrolling
Updated: 8/17/2012
CSRA Partners in Health
mi
from
Augusta, GA
Click here to add this to my saved trials
Weight Loss Study for People With Type 2 Diabetes
Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes
Status: Enrolling
Updated:  8/17/2012
Northwestern University Feinberg School
mi
from
Chicago, IL
Weight Loss Study for People With Type 2 Diabetes
Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes
Status: Enrolling
Updated: 8/17/2012
Northwestern University Feinberg School
mi
from
Chicago, IL
Click here to add this to my saved trials
Weight Loss Study for People With Type 2 Diabetes
Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes
Status: Enrolling
Updated:  8/17/2012
Obesity Research Center St. Luke's Roosevelt Hospital Center
mi
from
New York, NY
Weight Loss Study for People With Type 2 Diabetes
Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes
Status: Enrolling
Updated: 8/17/2012
Obesity Research Center St. Luke's Roosevelt Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
Weight Loss Study for People With Type 2 Diabetes
Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes
Status: Enrolling
Updated:  8/17/2012
Weill Medical College of Cornell University
mi
from
New York, NY
Weight Loss Study for People With Type 2 Diabetes
Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes
Status: Enrolling
Updated: 8/17/2012
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Weight Loss Study for People With Type 2 Diabetes
Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes
Status: Enrolling
Updated:  8/17/2012
The Center For Nutrition and Preventive Medicine
mi
from
Charlotte, NC
Weight Loss Study for People With Type 2 Diabetes
Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes
Status: Enrolling
Updated: 8/17/2012
The Center For Nutrition and Preventive Medicine
mi
from
Charlotte, NC
Click here to add this to my saved trials
Weight Loss Study for People With Type 2 Diabetes
Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes
Status: Enrolling
Updated:  8/17/2012
Obesity Clinical Trials Program Duke University Medical Center
mi
from
Durham, NC
Weight Loss Study for People With Type 2 Diabetes
Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes
Status: Enrolling
Updated: 8/17/2012
Obesity Clinical Trials Program Duke University Medical Center
mi
from
Durham, NC
Click here to add this to my saved trials